Biotech · Private company
Egetis Therapeutics AB (publ)
Track this companyFree. Adds Egetis Therapeutics AB (publ) to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Calmangafodipir (2 µmol/kg)Phase 3 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Calmangafodipir (5 µmol/kg)Phase 3 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)PHASE3 · COMPLETED · started Jul 21, 2023ClinicalTrials.gov NCT05579327 · fetched Nov 12, 2026
- Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)PHASE3 · TERMINATED · started Nov 7, 2018ClinicalTrials.gov NCT03654729 · fetched Nov 12, 2026
- Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 DeficiencyAPPROVED_FOR_MARKETINGClinicalTrials.gov NCT05911399 · fetched Nov 12, 2026